Vigabatrin Tablet, Film Coated
Product Images NDC 70710-1287

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Vigabatrin (NDC 70710-1287). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Zydus Pharmaceuticals (usa) Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (Fcbe09cd 50af 4932 8f4a 6f6439068b4d 01)

Chemical structure of vigabatrin, showing its molecular framework with functional groups including an amino group (NH2), a carboxylic acid group (COOH), and an alkene moiety. This diagram represents the active ingredient vigabatrin.*

FDA Label Image

Image (Fcbe09cd 50af 4932 8f4a 6f6439068b4d 02)

A Kaplan-Meier type chart showing the percentage reduction in seizure frequency versus the percentage of patients for vigabatrin (labeled as VGB) at doses of 1g/day, 3g/day, and 6g/day compared with placebo. The vertical axis represents % reduction in seizure frequency ranging from -100 (worsening) to 100 (improvement), and the horizontal axis shows % of patients from 100 to 0. Curves illustrate patient response, with higher doses generally showing greater improvement.*

FDA Label Image

Image (Fcbe09cd 50af 4932 8f4a 6f6439068b4d 03)

A cumulative distribution plot showing percentage reduction in seizure frequency on the vertical axis against percentage of patients on the horizontal axis. The graph compares seizure frequency changes between placebo and 3g/day vigabatrin (VGB) treatment groups, with axes indicating improvement or worsening in seizure frequency.*

FDA Label Image

Image (Fcbe09cd 50af 4932 8f4a 6f6439068b4d 16)

Label for Vigabatrin Tablets, USP 500 mg, oral film-coated tablets by Zydus Pharmaceuticals (USA) Inc. The label includes the NDC 70710-1287-1, dosage strength, pharmacist dispensing instructions, storage conditions (20° to 25°C), child-resistant packaging notice, and manufacturer details (Cadila Healthcare Ltd., India). The package contains 100 tablets and is prescription-only.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.